0.55T MRI 引导下经会阴前列腺穿刺活检的临床可行性
本研究纳入了 19 例疑似前列腺癌的参与者,评估在大孔径(80 cm)0.55T 扫描仪上进行 MRI 引导下前列腺穿刺活检的可行性。结果显示,在 0.55T MRI 上识别并准确靶向可疑前列腺病灶是可行的,且可检测出多种 ISUP 分级组的前列腺癌。
要点
- 0.55T 大孔径 MRI 可用于前列腺病灶定位及引导穿刺活检,技术可行。
- 共活检 20 个病灶,其中 20% 为良性,阳性针芯比例范围为 10% 至 100%。
- 在既往有活检史的参与者中,22.2%(2/9)检测出新发癌症,22.2%(2/9)出现 ISUP 分级升级。
核心结论
- 使用 0.55T MRI 扫描仪识别并准确靶向可疑前列腺病灶是可行的。
研究设计与样本
- 经机构审查委员会(IRB)批准的前瞻性研究,于 2023 年 5 月至 2024 年 10 月招募 19 例疑似前列腺癌参与者(年龄 68 ± 10 岁),其中 17 例接受了活检(4 例经直肠,13 例经皮),2 例被排除;使用大孔径(80 cm)0.55T 扫描仪,以活检前诊断扫描和术中 T2 加权图像进行病灶定位。
诊断标准与关键数值
- 共活检 20 个病灶(平均大小 1.9 ± 1.2 cm),阳性针芯比例范围为 10% 至 100%,20% 的病灶为良性;在既往有活检史的参与者中,22.2%(2/9)检测出新发癌症,22.2%(2/9)出现 ISUP 分级组升级,33.3%(3/9)阳性针芯体积增加,11.1%(1/9)无升级,11.1%(1/9)为良性发现;在初次活检参与者中,75%(6/8)检测出癌症,25%(2/8)为良性发现。
临床应用与阅片要点
- 经直肠活检的平均总手术时间为 77 ± 21 分钟,经皮活检为 74 ± 22 分钟;首次取芯时间分别为 45 ± 15 分钟和 53 ± 14 分钟;一例新发癌症在髋关节假体附近被检测到,归因于成像伪影减少。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVE: In-bore MRI-guided biopsy allows direct visualization of suspicious lesions, biopsy needles, and trajectories, allowing accurate sampling when MRI-ultrasound fusion biopsy is not feasible. However, its use has been limited. Wide-bore, lower-field, and lower-cost scanners could help address these issues, but their feasibility for prostate biopsy is unknown. The purpose of our study was to evaluate the feasibility of in-bore MRI-guided prostate biopsy using a large-bore (80 cm), 0.55T scanner.
MATERIALS AND METHODS: Nineteen participants (68 ± 10 years) with suspected prostate cancer (PCa) were recruited for this Institutional Review Board (IRB) approved study (May 2023 -October 2024). Prebiopsy diagnostic scans and intra-procedural T2-weighted images were used for lesion localization. PSA levels, lesion sizes, cancer detection rates, positive core volume percentage, ISUP (International Society of Urological Pathology) grade groups (GG), positive volume cores, skin to target distances, and procedure durations were reported.
RESULTS: Seventeen participants underwent biopsies (four transrectal, thirteen percutaneous). Two participants were excluded. Twenty lesions (mean size 1.9 ± 1.2 cm) were biopsied which showed various GG cancers (GG1, GG2, GG3, GG4, and GG5), with positive cores ranging from 10 to 100%. 20% of the lesions were benign. Compared to previous biopsies, 22.2% (2/9) had new cancer detections, 22.2% (2/9) showed a GG upgrade, and 33.3% (3/9) had increased positive core volume, while 11.1% (1/9) showed no upgrade and 11.1% (1/9) had benign findings. Among biopsy-naïve participants, 75% (6/8) had cancer detected, and 25% (2/8) had benign findings. One new cancer was detected near a hip prosthesis due to reduced imaging artifacts. Average total procedure time was 77 ± 21 min for transrectal and 74 ± 22 min for percutaneous biopsies, with times to first core at 45 ± 15 and 53 ± 14 min, respectively.
CONCLUSION: Identifying and accurately targeting suspicious prostate lesions is feasible using a 0.55T MRI scanner.
引用
- Kaur T, Jiang Y, Seiberlich N, et al. Clinical feasibility of MRI-guided in-bore prostate biopsies at 0.55T. Abdom Radiol (NY). 2025. PMID: 39794536. doi:10.1007/s00261-024-04783-x
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。